Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
SEC Accession No. 0001193125-24-216596
Filing Date
2024-09-10
Accepted
2024-09-10 16:02:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC TO-I/A d869029dsctoia.htm SC TO-I/A 15845
2 EX-99.(A)(1)(L) d869029dex99a1l.htm EX-99.(A)(1)(L) 4536
  Complete submission text file 0001193125-24-216596.txt   22408
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filed by) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: SC TO-I/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: SC TO-I/A | Act: 34 | File No.: 005-91457 | Film No.: 241290060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)